• 1. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 2. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 3. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 4. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 5. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538

Introduction to 3-(Difluoromethoxy)benzene-1-sulfonyl chloride (CAS No. 351003-38-8)

3-(Difluoromethoxy)benzene-1-sulfonyl chloride, identified by the Chemical Abstracts Service Number (CAS No.) 351003-38-8, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical and chemical research. This compound belongs to the class of sulfonyl chlorides, which are widely recognized for their utility as intermediates in the synthesis of various bioactive molecules. The presence of both a difluoromethoxy group and a sulfonyl chloride functionality makes this molecule particularly intriguing, as these structural features can impart unique chemical properties that are highly valuable in medicinal chemistry and material science.

The difluoromethoxy group, specifically, is a fluorinated ether moiety that has been extensively studied for its ability to modulate the pharmacokinetic and pharmacodynamic properties of drug candidates. Fluorine atoms are known to enhance metabolic stability, improve binding affinity to biological targets, and influence the overall solubility and bioavailability of compounds. In contrast, the sulfonyl chloride group is a well-established electrophile that serves as a versatile synthetic handle for introducing sulfonamide functionalities into molecular frameworks. This combination of features in 3-(Difluoromethoxy)benzene-1-sulfonyl chloride makes it a promising building block for the development of novel therapeutic agents.

In recent years, there has been a surge in research focused on the design and synthesis of molecules containing fluorinated aromatic systems. The ability to fine-tune electronic and steric properties through fluorine substitution has opened up new avenues for drug discovery. For instance, studies have demonstrated that the introduction of fluorine atoms can lead to improved receptor binding by altering hydrophobic interactions and hydrogen bonding patterns. Additionally, the difluoromethoxy group has been shown to enhance lipophilicity, which is often a critical factor in drug transport across biological membranes.

3-(Difluoromethoxy)benzene-1-sulfonyl chloride (CAS No. 351003-38-8) has found applications in the synthesis of various pharmacologically active compounds. One notable area of interest is its use as an intermediate in the preparation of sulfonamide-based drugs, which are known for their broad spectrum of biological activity. Sulfonamides have been used successfully in treating infections, inflammation, and even certain types of cancer. The sulfonyl chloride moiety allows for facile coupling with amines to form sulfonamides, making this compound a valuable reagent in medicinal chemistry laboratories.

Moreover, the unique electronic properties of the difluoromethoxy group have been exploited in material science applications. For example, fluorinated aromatic compounds have been investigated for their potential use as organic semiconductors and liquid crystals due to their ability to exhibit high thermal stability and tunable electronic characteristics. The synthesis of advanced materials often relies on such intermediates to achieve desired physical properties.

Recent advancements in synthetic methodologies have further enhanced the utility of 3-(Difluoromethoxy)benzene-1-sulfonyl chloride (CAS No. 351003-38-8). Techniques such as transition-metal-catalyzed cross-coupling reactions have enabled chemists to construct complex molecular architectures with greater efficiency and selectivity. These methods have allowed for the rapid diversification of libraries containing this intermediate, facilitating high-throughput screening programs aimed at identifying novel drug candidates.

The pharmaceutical industry has also benefited from the growing body of knowledge surrounding fluorinated sulfonyl chlorides. Researchers have developed innovative strategies to incorporate these moieties into drug molecules while maintaining or improving their therapeutic efficacy. For instance, studies have shown that certain fluorinated sulfonamides exhibit enhanced antiviral and anticancer activities compared to their non-fluorinated counterparts. This underscores the importance of carefully selecting structural motifs like those found in 3-(Difluoromethoxy)benzene-1-sulfonyl chloride when designing new therapeutic agents.

In conclusion, 3-(Difluoromethoxy)benzene-1-sulfonyl chloride (CAS No. 351003-38-8) represents a versatile and highly functional compound with significant potential in both academic research and industrial applications. Its unique combination of structural features makes it an invaluable tool for synthetic chemists working on pharmaceuticals and advanced materials. As our understanding of fluorinated systems continues to evolve, it is likely that this compound will play an even greater role in shaping the future of chemical biology and drug discovery.

• 1010422-55-5(2-Methoxy-5-(trifluoromethoxy)-benzenesulfonyl chloride)
• 103008-51-1(2-(Trifluoromethoxy)benzenesulfonyl chloride)
• 94108-56-2(4-(trifluoromethoxy)benzenesulfonyl chloride)
• 10130-74-2(3-Methoxybenzenesulfanyl chloride)
• 351003-34-4(4-(Difluoromethoxy)benzene-1-sulfonyl chloride)
• 91168-60-4(Benzenesulfonyl chloride, 2,5-bis(difluoromethoxy)-)
• 220227-84-9(3-(Trifluoromethoxy)benzenesulfonyl Chloride)
• 873203-39-5(Benzenesulfonyl chloride, 4-[4-(trifluoromethoxy)phenoxy]-)
• 1154355-35-7(2-(difluoromethoxy)-5-methoxybenzene-1-sulfonyl chloride)
• 77798-10-8(2-Difluoromethoxy-benzenesulfonyl chloride)